Ndustrial Raises $18.5M Series B First Close
Ndustrial, a Raleigh, NC-based provider of a AI-powered energy intensity platform for industry, raised $18.5M in Series B funding.
Ndustrial, a Raleigh, NC-based provider of a AI-powered energy intensity platform for industry, raised $18.5M in Series B funding.
Squarespace (NYSE: SQSP), a NYC-based provider of a design-driven platform helping entrepreneurs build brands and businesses online, entered into a definitive agreement to go private by Permira, the global private equity firm, in an all-cash transaction valued at approximately $6.9 Billion.
JanOne Inc. (Nasdaq: JAN), a Las Vegas, NV-based company offering solutions to help end the opioid crisis, is to acquire ALT 5 Sigma Inc., a Delaware corporation, blockchain financial technology provider, and each of its wholly-owned subsidiaries.
Summit Wash Holdings, a Palm Beach Gardens, FL- and Norwalk, CT-based membership-focused car wash group currently operating 54 sites, received $200M+ in debt financing.
Monitaur, a Boston, MA-based model governance software company, raised $6M in Series A funding.
ByHeart, a NYC-based infant nutrition company, raised $95M in funding.
Pepper, a NYC-based technology partner for the food distribution sector, raised $30M in Series B funding.
Mitra Future Technologies, Inc., a Mountain View, CA-based innovator in North American lithium-ion battery materials, received an investment from Alpha Wave Ventures as part of a Series B funding round.
Switchboard Health, a Boise, ID-based creator of a high-value specialty care network and software platform, raised $6.5M in seed funding.
Haveli Investments, an Austin, TX-based technology-focused private equity firm, acquired ZeroFox (Nasdaq: ZFOX), a Baltimore, MD-based provider of external cybersecurity.
Active Surfaces, a Woburn, MA-based flexible solar panel startup spun out from MIT, raised $5.6M in pre-seed funding.
Princenton NuEnergy, a Bordentown, NJ-based clean-tech innovator specializing in lithium-ion battery direct recycling, raised additional $10.3M in Series A funding.
Ajax Therapeutics, a NYC- and Cambridge, MA-based biopharmaceutical company developing JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), raised $95M in Series C funding.
CereVasc, a Boston, MA-based clinical-stage, medical device company, raised $70M in Series B funding.
Roam, A NYC-based provider of a platform for assumable mortgages, raised $3M in additional funding.